Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04682977
Other study ID # 2020-1461
Secondary ID 5P30AG022849-17
Status Completed
Phase N/A
First received
Last updated
Start date April 22, 2021
Est. completion date March 1, 2024

Study information

Verified date June 2024
Source University of Illinois at Chicago
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.


Description:

The IPROACTIF intervention is based on the premise of preventing the physical and cognitive decline that is associated with aging and chronic disease. The 12-week intervention includes a comprehensive assessment of ADL functioning and ten intervention sessions addressing disease management, physical activity and executive functioning. This pilot randomized control trial will compare whether patients who receive IPROACTIF perform better than usual care patients on physical functioning, self-efficacy for chronic disease management, physical activity levels, executive functioning, health-related quality of life, and participation in life roles and activities.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date March 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers No
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria: - English speaking - Community-dwelling - 55 years of age - Primary diagnosis of heart disease (coronary artery disease, ischemic heart disease, hypertensive heart disease), or uncontrolled diabetes (HBA1c greater than/equal to 10) - Self-reported risk of functional decline (score of 3 or higher) on the 11-item Brief Risk Identification of Geriatric Health Tool or self-reported need for assistance with disease management Exclusion Criteria - Current/past diagnosis of stroke or other neurological disorders - Receiving pharmacological treatment for cognition - Participating in other exercise or ADL-focused intervention studies - Non-English speaking - Residing in a long-term care institution - Compromised decision-making capacity (score >8 on SOMCT)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning)
IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) is an intervention designed to be delivered in primary care settings by an on-site occupational therapist. Based on the premise of preventing the physical and cognitive decline that is associated with aging and chronic disease, the 12-week intervention includes a comprehensive assessment of ADL functioning and ten intervention sessions addressing disease management, physical activity and executive functioning.
Usual primary care services
Usual primary care services might include monitoring of vitals and other relevant laboratory testing, prescription of medications for chronic disease management, as well as counseling for lifestyle changes.

Locations

Country Name City State
United States University of Illinois at Chicago Chicago Illinois

Sponsors (2)

Lead Sponsor Collaborator
University of Illinois at Chicago National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical functioning measured using the PROMIS Physical Function Short Form 20 Self-reported assessment with raw scores ranging from 20 to 100; higher scores indicate better physical functioning 12 weeks
Primary Physical functioning measured using the Patient-Specific Functional Scale Self-reported assessment; scoring depends on number of activities rated, for a single activity, scores can range from 0 to 10; higher scores indicate better physical functioning 12 weeks
Primary Physical functioning measured using the Physical Performance Test (9-item) Performance-based assessment; scores can range from 0 to 36; higher scores indicate better physical functioning 12 weeks
Primary Performance of daily living tasks using the Performance Assessment of Self-care Skills Performance-based measure; summary score for each task ranges from 0-12; higher scores indicate better performance 12 weeks
Primary Executive functioning using the Dimensional Change Card Sort Test Performance-based measure; scores range from 0-10; higher scores indicate better performance 12 weeks
Primary Executive functioning using the Executive Function Performance Test Performance-based measure; only the medication management task will be used; scores range from 0-25 for this task; higher scores indicate poorer performance 12 weeks
Secondary Physical activity level Total minutes per day in moderate to vigorous physical activity and sedentary activity as measured by an accelerometer worn for at least 12 hours over seven consecutive days. 12 weeks
Secondary Self-efficacy for chronic disease management using the Chronic Disease Self-Efficacy and Self-Management Measures Self-reported assessment; range of possible scores varies by subscale; generally higher scores indicate better self-efficacy and self-management 12 weeks
Secondary Health related quality of life using the PROMIS Global Health Measure (physical and mental subscales) Self-reported assessment; raw scores for both sub-scales range from 4-20; higher score indicated better health-related quality of life 12 weeks
Secondary Participation in life activities and roles using the Late Life Functioning and Disability Index Self-rated measure; scaled scores for both dimensions (frequency and limitation) range from 0-100; higher scores indicate less difficulty i.e. better performance 12 weeks